Your browser doesn't support javascript.
loading
Lyophilized Progenitor Tenocyte Extracts: Sterilizable Cytotherapeutic Derivatives with Antioxidant Properties and Hyaluronan Hydrogel Functionalization Effects.
Laurent, Alexis; Porcello, Alexandre; Jeannerat, Annick; Peneveyre, Cédric; Coeur, Agathe; Abdel-Sayed, Philippe; Scaletta, Corinne; Michetti, Murielle; de Buys Roessingh, Anthony; Jordan, Olivier; Allémann, Eric; Raffoul, Wassim; Hirt-Burri, Nathalie; Applegate, Lee Ann.
Afiliação
  • Laurent A; Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, CH-1066 Epalinges, Switzerland.
  • Porcello A; Applied Research Department, LAM Biotechnologies SA, CH-1066 Epalinges, Switzerland.
  • Jeannerat A; School of Pharmaceutical Sciences, University of Geneva, CH-1206 Geneva, Switzerland.
  • Peneveyre C; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CH-1206 Geneva, Switzerland.
  • Coeur A; Applied Research Department, LAM Biotechnologies SA, CH-1066 Epalinges, Switzerland.
  • Abdel-Sayed P; Applied Research Department, LAM Biotechnologies SA, CH-1066 Epalinges, Switzerland.
  • Scaletta C; School of Pharmaceutical Sciences, University of Geneva, CH-1206 Geneva, Switzerland.
  • Michetti M; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CH-1206 Geneva, Switzerland.
  • de Buys Roessingh A; Engineering Cycle, Ecole de Biologie Industrielle, F-95885 Cergy, France.
  • Jordan O; Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, CH-1066 Epalinges, Switzerland.
  • Allémann E; DLL Bioengineering, Discovery Learning Program, STI School of Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
  • Raffoul W; Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, CH-1066 Epalinges, Switzerland.
  • Hirt-Burri N; Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, CH-1066 Epalinges, Switzerland.
  • Applegate LA; Children and Adolescent Surgery Service, Lausanne University Hospital, University of Lausanne, CH-1011 Lausanne, Switzerland.
Antioxidants (Basel) ; 12(1)2023 Jan 10.
Article em En | MEDLINE | ID: mdl-36671025
ABSTRACT
Cultured primary progenitor tenocytes in lyophilized form were previously shown to possess intrinsic antioxidant properties and hyaluronan-based hydrogel viscosity-modulating effects in vitro. The aim of this study was to prepare and functionally characterize several stabilized (lyophilized) cell-free progenitor tenocyte extracts for inclusion in cytotherapy-inspired complex injectable preparations. Fractionation and sterilization methods were included in specific biotechnological manufacturing workflows of such extracts. Comparative and functional-oriented characterizations of the various extracts were performed using several orthogonal descriptive, colorimetric, rheological, mechanical, and proteomic readouts. Specifically, an optimal sugar-based (saccharose/dextran) excipient formula was retained to produce sterilizable cytotherapeutic derivatives with appropriate functions. It was shown that extracts containing soluble cell-derived fractions possessed conserved and significant antioxidant properties (TEAC) compared to the freshly harvested cellular starting materials. Progenitor tenocyte extracts submitted to sub-micron filtration (0.22 µm) and 60Co gamma irradiation terminal sterilization (5−50 kGy) were shown to retain significant antioxidant properties and hyaluronan-based hydrogel viscosity modulating effects. Hydrogel combination products displayed important efficacy-related characteristics (friction modulation, tendon bioadhesivity) with significant (p < 0.05) protective effects of the cellular extracts in oxidative environments. Overall, the present study sets forth robust control methodologies (antioxidant assays, H2O2-challenged rheological setups) for stabilized cell-free progenitor tenocyte extracts. Importantly, it was shown that highly sensitive phases of cytotherapeutic derivative manufacturing process development (purification, terminal sterilization) allowed for the conservation of critical biological extract attributes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Antioxidants (Basel) Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Antioxidants (Basel) Ano de publicação: 2023 Tipo de documento: Article